This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Signaling by the tyrosine kinase Yes promotes liver cancer development.
Science signaling · 2022
Very-long-chain fatty acid metabolic capacity of 17-beta-hydroxysteroid dehydrogenase type 12 (HSD17B12) promotes replication of hepatitis C virus and related flaviviruses.
Scientific reports · 2020 · senior author
Biodegradation of the endogenous residue of activated sludge.
Water research · 2010
Latest funding
The National CIHR Hepatitis C Network (NCHCN)
CIHR · 2015 · Co-investigator
- $100,000
Functional characterization of new regulators of the innate antiviral immunity to develop broad-spectrum antiviral therapies
CIHR · 2015 · Nominated PI
- $331,700
Functional characterization of new regulators of the innate antiviral immunity
CIHR · 2011 · Nominated PI
7 publications.
Signaling by the tyrosine kinase Yes promotes liver cancer development.
Guégan JP, Lapouge M, Voisin L, Saba-El-Leil MK, Tanguay PL, Lévesque K, Brégeon J, Mes-Masson AM, Lamarre D, Haibe-Kains B, Trinh VQ, Soucy G, Bilodeau M, Meloche S
Very-long-chain fatty acid metabolic capacity of 17-beta-hydroxysteroid dehydrogenase type 12 (HSD17B12) promotes replication of hepatitis C virus and related flaviviruses.
Mohamed B, Mazeaud C, Baril M, Poirier D, Sow AA, Chatel-Chaix L, Titorenko V, Lamarre D
Biodegradation of the endogenous residue of activated sludge.
Ramdani A, Dold P, Déléris S, Lamarre D, Gadbois A, Comeau Y
In situ characterization of nitrifying biofilm: minimizing biomass loss and preserving perspective.
Delatolla R, Tufenkji N, Comeau Y, Lamarre D, Gadbois A, Berk D
Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.
Voisin L, Julien C, Duhamel S, Gopalbhai K, Claveau I, Saba-El-Leil MK, Rodrigue-Gervais IG, Gaboury L, Lamarre D, Basik M, Meloche S
Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes.
Thibodeau J, Bourgeois-Daigneault MC, Huppé G, Tremblay J, Aumont A, Houde M, Bartee E, Brunet A, Gauvreau ME, de Gassart A, Gatti E, Baril M, Cloutier M, Bontron S, Früh K, Lamarre D, Steimle V
New treatment strategies against hepatitis C viral infection.
Bilodeau M, Lamarre D
The National CIHR Hepatitis C Network (NCHCN)
Principal investigators: Shoukry, Naglaa H; Wong, Thomas; Bruneau, Julie; Feld, Jordan J; Krajden, Mel; Richardson, Christopher D
Keywords: Aboriginals; Hepatitis C; Liver Cancer; Liver Disease; People Who Inject Drugs; Public Health; Risk Factors; Therapy; Vaccines; Viral Transmission
Functional characterization of new regulators of the innate antiviral immunity to develop broad-spectrum antiviral therapies
Principal investigators: Lamarre, Daniel
Keywords: Beta-Catenin; Chemogenomics; Functinal Genomics; High-Throughput Screening; Innate Antiviral Immunity; Proteomics; Snrnp200; Spliceosome; Stress Response; Wnt Pathway
Functional characterization of new regulators of the innate antiviral immunity
Principal investigators: Lamarre, Daniel
Keywords: Bioluminescence Resonance Energy Transfert; Chemogenomics; Hepatitis C Virus; High-Throughput Screening; Human Immunodeficiency Virus; Innate Antiviral Immunity; Molecular Interaction Networks; Rna Interference; Viral Replication And Infection; Virus-Host Interactions
Molecular dissection of HCV life cycle through the study of virus/host interactome.
Principal investigators: Lamarre, Daniel
Keywords: Bioluminescence Resonance Energy Transfer; Chemogenomics; Hepatitis C Virus; Ns3/4a Protease; Ns5a; Particle Assembly; Quantitative Mass Spectrometry; Rna Replication; Virus Host-Interactions; Y-Box Protein 1
Identification of new regulators of the innate antiviral response using a genome-scale lentiviral-based RNAi screen.
Principal investigators: Lamarre, Daniel
Keywords: Genome-Wide Screen; Hepatitis C Virus; Innate Immunity; Rnai
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Médecine
- Institut de recherche en immunologie et cancer
- Medicine
- Radiation Oncology/Medical Physics
- Molecular Medicine
- Centre Armand-Frappier Santé Biotechnologie
- Cancer Research
- Other
Co-authors at Université de Montréal, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Sylvain Meloche
Institut de recherche en immunologie et cancer
2 shared papers, latest 2022
Laurent Chatel-Chaix
Centre Armand-Frappier Santé Biotechnologie
1 shared papers, latest 2020
Mark Basik
Social Studies of Medicine
1 shared papers, latest 2008
Marie-Claude Bourgeois-Daigneault
Cancer Research
1 shared papers, latest 2008
Donald Poirier
Molecular Medicine
1 shared papers, latest 2020
Jacques Thibodeau
Faculty
1 shared papers, latest 2008
Benjamin Haibe-Kains
Radiation Oncology/Medical Physics
1 shared papers, latest 2022
Anne-Marie Mes-Masson
Medicine
1 shared papers, latest 2022
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.